The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Bioresorbable Drug-Eluting Stents market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Bioresorbable Drug-Eluting Stents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Bioresorbable Drug-Eluting Stents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Bioresorbable Drug-Eluting Stents include Medtronic, Abbott, Johnson & Johnson, Bostonscientific, B. Braun Melsungen AG, Lepu Medical, Microport, JW Medical and Lifetech Scientific, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Bioresorbable Drug-Eluting Stents in Under 50 Years Old is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Metal Based, which accounted for % of the global market of Bioresorbable Drug-Eluting Stents in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioresorbable Drug-Eluting Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioresorbable Drug-Eluting Stents.
The Bioresorbable Drug-Eluting Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Bioresorbable Drug-Eluting Stents market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioresorbable Drug-Eluting Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Medtronic
- Abbott
- Johnson & Johnson
- Bostonscientific
- B. Braun Melsungen Ag
- Lepu Medical
- Microport
- Jw Medical
- Lifetech Scientific
- Yinyi Biotech
Product Type Insights
Global markets are presented by Bioresorbable Drug-Eluting Stents type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Bioresorbable Drug-Eluting Stents are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Bioresorbable Drug-Eluting Stents segment by Materials
- Metal Based
- Polymer
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Bioresorbable Drug-Eluting Stents market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Bioresorbable Drug-Eluting Stents market.
Bioresorbable Drug-Eluting Stents segment by Application
- Under 50 Years Old
- Abover 50 Years Old
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Bioresorbable Drug-Eluting Stents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioresorbable Drug-Eluting Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Bioresorbable Drug-Eluting Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Bioresorbable Drug-Eluting Stents industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioresorbable Drug-Eluting Stents.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bioresorbable Drug-Eluting Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bioresorbable Drug-Eluting Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index
1 Bioresorbable Drug-Eluting Stents Market Overview
1.1 Product Overview and Scope of Bioresorbable Drug-Eluting Stents
1.2 Bioresorbable Drug-Eluting Stents Segment by Materials
1.2.1 Global Bioresorbable Drug-Eluting Stents Sales Growth Rate Comparison by Materials (2022-2028)
1.2.2 Metal Based
1.2.3 Polymer
1.3 Bioresorbable Drug-Eluting Stents Segment by Application
1.3.1 Global Bioresorbable Drug-Eluting Stents Sales Comparison by Application: (2022-2028)
1.3.2 Under 50 Years Old
1.3.3 Abover 50 Years Old
1.4 Global Bioresorbable Drug-Eluting Stents Market Size Estimates and Forecasts
1.4.1 Global Bioresorbable Drug-Eluting Stents Revenue 2017-2028
1.4.2 Global Bioresorbable Drug-Eluting Stents Sales 2017-2028
1.4.3 Bioresorbable Drug-Eluting Stents Market Size by Region: 2017 Versus 2021 Versus 2028
2 Bioresorbable Drug-Eluting Stents Market Competition by Manufacturers
2.1 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Manufacturers (2017-2022)
2.2 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Bioresorbable Drug-Eluting Stents Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Bioresorbable Drug-Eluting Stents Manufacturing Sites, Area Served, Product Type
2.5 Bioresorbable Drug-Eluting Stents Market Competitive Situation and Trends
2.5.1 Bioresorbable Drug-Eluting Stents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bioresorbable Drug-Eluting Stents Players Market Share by Revenue
2.5.3 Global Bioresorbable Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bioresorbable Drug-Eluting Stents Retrospective Market Scenario by Region
3.1 Global Bioresorbable Drug-Eluting Stents Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Bioresorbable Drug-Eluting Stents Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Bioresorbable Drug-Eluting Stents Market Facts & Figures by Country
3.3.1 North America Bioresorbable Drug-Eluting Stents Sales by Country
3.3.2 North America Bioresorbable Drug-Eluting Stents Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Bioresorbable Drug-Eluting Stents Market Facts & Figures by Country
3.4.1 Europe Bioresorbable Drug-Eluting Stents Sales by Country
3.4.2 Europe Bioresorbable Drug-Eluting Stents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bioresorbable Drug-Eluting Stents Market Facts & Figures by Region
3.5.1 Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region
3.5.2 Asia Pacific Bioresorbable Drug-Eluting Stents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Bioresorbable Drug-Eluting Stents Market Facts & Figures by Country
3.6.1 Latin America Bioresorbable Drug-Eluting Stents Sales by Country
3.6.2 Latin America Bioresorbable Drug-Eluting Stents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bioresorbable Drug-Eluting Stents Market Facts & Figures by Country
3.7.1 Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Country
3.7.2 Middle East and Africa Bioresorbable Drug-Eluting Stents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Bioresorbable Drug-Eluting Stents Historic Market Analysis by Materials
4.1 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Materials (2017-2022)
4.2 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Materials (2017-2022)
4.3 Global Bioresorbable Drug-Eluting Stents Price by Materials (2017-2022)
5 Global Bioresorbable Drug-Eluting Stents Historic Market Analysis by Application
5.1 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2017-2022)
5.2 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Application (2017-2022)
5.3 Global Bioresorbable Drug-Eluting Stents Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Medtronic Bioresorbable Drug-Eluting Stents Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Abbott Bioresorbable Drug-Eluting Stents Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Johnson & Johnson Bioresorbable Drug-Eluting Stents Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Bostonscientific
6.4.1 Bostonscientific Corporation Information
6.4.2 Bostonscientific Description and Business Overview
6.4.3 Bostonscientific Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bostonscientific Bioresorbable Drug-Eluting Stents Product Portfolio
6.4.5 Bostonscientific Recent Developments/Updates
6.5 B. Braun Melsungen AG
6.5.1 B. Braun Melsungen AG Corporation Information
6.5.2 B. Braun Melsungen AG Description and Business Overview
6.5.3 B. Braun Melsungen AG Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.5.4 B. Braun Melsungen AG Bioresorbable Drug-Eluting Stents Product Portfolio
6.5.5 B. Braun Melsungen AG Recent Developments/Updates
6.6 Lepu Medical
6.6.1 Lepu Medical Corporation Information
6.6.2 Lepu Medical Description and Business Overview
6.6.3 Lepu Medical Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Lepu Medical Bioresorbable Drug-Eluting Stents Product Portfolio
6.6.5 Lepu Medical Recent Developments/Updates
6.7 Microport
6.6.1 Microport Corporation Information
6.6.2 Microport Description and Business Overview
6.6.3 Microport Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Microport Bioresorbable Drug-Eluting Stents Product Portfolio
6.7.5 Microport Recent Developments/Updates
6.8 JW Medical
6.8.1 JW Medical Corporation Information
6.8.2 JW Medical Description and Business Overview
6.8.3 JW Medical Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.8.4 JW Medical Bioresorbable Drug-Eluting Stents Product Portfolio
6.8.5 JW Medical Recent Developments/Updates
6.9 Lifetech Scientific
6.9.1 Lifetech Scientific Corporation Information
6.9.2 Lifetech Scientific Description and Business Overview
6.9.3 Lifetech Scientific Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Lifetech Scientific Bioresorbable Drug-Eluting Stents Product Portfolio
6.9.5 Lifetech Scientific Recent Developments/Updates
6.10 Yinyi Biotech
6.10.1 Yinyi Biotech Corporation Information
6.10.2 Yinyi Biotech Description and Business Overview
6.10.3 Yinyi Biotech Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Yinyi Biotech Bioresorbable Drug-Eluting Stents Product Portfolio
6.10.5 Yinyi Biotech Recent Developments/Updates
7 Bioresorbable Drug-Eluting Stents Manufacturing Cost Analysis
7.1 Bioresorbable Drug-Eluting Stents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bioresorbable Drug-Eluting Stents
7.4 Bioresorbable Drug-Eluting Stents Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bioresorbable Drug-Eluting Stents Distributors List
8.3 Bioresorbable Drug-Eluting Stents Customers
9 Bioresorbable Drug-Eluting Stents Market Dynamics
9.1 Bioresorbable Drug-Eluting Stents Industry Trends
9.2 Bioresorbable Drug-Eluting Stents Market Drivers
9.3 Bioresorbable Drug-Eluting Stents Market Challenges
9.4 Bioresorbable Drug-Eluting Stents Market Restraints
10 Global Market Forecast
10.1 Bioresorbable Drug-Eluting Stents Market Estimates and Projections by Materials
10.1.1 Global Forecasted Sales of Bioresorbable Drug-Eluting Stents by Materials (2023-2028)
10.1.2 Global Forecasted Revenue of Bioresorbable Drug-Eluting Stents by Materials (2023-2028)
10.2 Bioresorbable Drug-Eluting Stents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bioresorbable Drug-Eluting Stents by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Bioresorbable Drug-Eluting Stents by Application (2023-2028)
10.3 Bioresorbable Drug-Eluting Stents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bioresorbable Drug-Eluting Stents by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Bioresorbable Drug-Eluting Stents by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Bioresorbable Drug-Eluting Stents Sales Growth Rate Comparison by Materials (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Bioresorbable Drug-Eluting Stents Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Bioresorbable Drug-Eluting Stents Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Bioresorbable Drug-Eluting Stents Market Competitive Situation by Manufacturers in 2021
Table 5. Global Bioresorbable Drug-Eluting Stents Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Bioresorbable Drug-Eluting Stents Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Bioresorbable Drug-Eluting Stents Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Bioresorbable Drug-Eluting Stents Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Bioresorbable Drug-Eluting Stents Manufacturing Sites and Area Served
Table 11. Manufacturers Bioresorbable Drug-Eluting Stents Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bioresorbable Drug-Eluting Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioresorbable Drug-Eluting Stents as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Bioresorbable Drug-Eluting Stents Sales by Region (2017-2022) & (K Units)
Table 16. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2017-2022)
Table 17. Global Bioresorbable Drug-Eluting Stents Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Region (2017-2022)
Table 19. North America Bioresorbable Drug-Eluting Stents Sales by Country (2017-2022) & (K Units)
Table 20. North America Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2017-2022)
Table 21. North America Bioresorbable Drug-Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2017-2022)
Table 23. Europe Bioresorbable Drug-Eluting Stents Sales by Country (2017-2022) & (K Units)
Table 24. Europe Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2017-2022)
Table 25. Europe Bioresorbable Drug-Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Bioresorbable Drug-Eluting Stents Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Bioresorbable Drug-Eluting Stents Revenue Market Share by Region (2017-2022)
Table 31. Latin America Bioresorbable Drug-Eluting Stents Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2017-2022)
Table 33. Latin America Bioresorbable Drug-Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Bioresorbable Drug-Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2017-2022)
Table 39. Global Bioresorbable Drug-Eluting Stents Sales by Materials (2017-2022) & (K Units)
Table 40. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Materials (2017-2022)
Table 41. Global Bioresorbable Drug-Eluting Stents Revenue by Materials (2017-2022) & (US$ Million)
Table 42. Global Bioresorbable Drug-Eluting Stents Revenue Share by Materials (2017-2022)
Table 43. Global Bioresorbable Drug-Eluting Stents Price by Materials (2017-2022) & (US$/Unit)
Table 44. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Application (2017-2022)
Table 45. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2017-2022)
Table 46. Global Bioresorbable Drug-Eluting Stents Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Bioresorbable Drug-Eluting Stents Revenue Share by Application (2017-2022)
Table 48. Global Bioresorbable Drug-Eluting Stents Price by Application (2017-2022) & (US$/Unit)
Table 49. Medtronic Corporation Information
Table 50. Medtronic Description and Business Overview
Table 51. Medtronic Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Medtronic Bioresorbable Drug-Eluting Stents Product
Table 53. Medtronic Recent Developments/Updates
Table 54. Abbott Corporation Information
Table 55. Abbott Description and Business Overview
Table 56. Abbott Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Abbott Bioresorbable Drug-Eluting Stents Product
Table 58. Abbott Recent Developments/Updates
Table 59. Johnson & Johnson Corporation Information
Table 60. Johnson & Johnson Description and Business Overview
Table 61. Johnson & Johnson Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Johnson & Johnson Bioresorbable Drug-Eluting Stents Product
Table 63. Johnson & Johnson Recent Developments/Updates
Table 64. Bostonscientific Corporation Information
Table 65. Bostonscientific Description and Business Overview
Table 66. Bostonscientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Bostonscientific Bioresorbable Drug-Eluting Stents Product
Table 68. Bostonscientific Recent Developments/Updates
Table 69. B. Braun Melsungen AG Corporation Information
Table 70. B. Braun Melsungen AG Description and Business Overview
Table 71. B. Braun Melsungen AG Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. B. Braun Melsungen AG Bioresorbable Drug-Eluting Stents Product
Table 73. B. Braun Melsungen AG Recent Developments/Updates
Table 74. Lepu Medical Corporation Information
Table 75. Lepu Medical Description and Business Overview
Table 76. Lepu Medical Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Lepu Medical Bioresorbable Drug-Eluting Stents Product
Table 78. Lepu Medical Recent Developments/Updates
Table 79. Microport Corporation Information
Table 80. Microport Description and Business Overview
Table 81. Microport Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Microport Bioresorbable Drug-Eluting Stents Product
Table 83. Microport Recent Developments/Updates
Table 84. JW Medical Corporation Information
Table 85. JW Medical Description and Business Overview
Table 86. JW Medical Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. JW Medical Bioresorbable Drug-Eluting Stents Product
Table 88. JW Medical Recent Developments/Updates
Table 89. Lifetech Scientific Corporation Information
Table 90. Lifetech Scientific Description and Business Overview
Table 91. Lifetech Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Lifetech Scientific Bioresorbable Drug-Eluting Stents Product
Table 93. Lifetech Scientific Recent Developments/Updates
Table 94. Yinyi Biotech Corporation Information
Table 95. Yinyi Biotech Description and Business Overview
Table 96. Yinyi Biotech Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Yinyi Biotech Bioresorbable Drug-Eluting Stents Product
Table 98. Yinyi Biotech Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Bioresorbable Drug-Eluting Stents Distributors List
Table 102. Bioresorbable Drug-Eluting Stents Customers List
Table 103. Bioresorbable Drug-Eluting Stents Market Trends
Table 104. Bioresorbable Drug-Eluting Stents Market Drivers
Table 105. Bioresorbable Drug-Eluting Stents Market Challenges
Table 106. Bioresorbable Drug-Eluting Stents Market Restraints
Table 107. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Materials (2023-2028) & (K Units)
Table 108. Global Bioresorbable Drug-Eluting Stents Sales Market Share Forecast by Materials (2023-2028)
Table 109. Global Bioresorbable Drug-Eluting Stents Revenue Forecast by Materials (2023-2028) & (US$ Million)
Table 110. Global Bioresorbable Drug-Eluting Stents Revenue Market Share Forecast by Materials (2023-2028)
Table 111. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Bioresorbable Drug-Eluting Stents Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Bioresorbable Drug-Eluting Stents Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Bioresorbable Drug-Eluting Stents Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Bioresorbable Drug-Eluting Stents Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Bioresorbable Drug-Eluting Stents Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Bioresorbable Drug-Eluting Stents Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bioresorbable Drug-Eluting Stents
Figure 2. Global Bioresorbable Drug-Eluting Stents Market Share by Materials in 2021 & 2028
Figure 3. Metal Based Product Picture
Figure 4. Polymer Product Picture
Figure 5. Global Bioresorbable Drug-Eluting Stents Market Share by Application in 2021 & 2028
Figure 6. Under 50 Years Old
Figure 7. Abover 50 Years Old
Figure 8. Global Bioresorbable Drug-Eluting Stents Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Bioresorbable Drug-Eluting Stents Market Size (2017-2028) & (US$ Million)
Figure 10. Global Bioresorbable Drug-Eluting Stents Sales (2017-2028) & (K Units)
Figure 11. Bioresorbable Drug-Eluting Stents Sales Share by Manufacturers in 2021
Figure 12. Global Bioresorbable Drug-Eluting Stents Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Bioresorbable Drug-Eluting Stents Players: Market Share by Revenue in 2021
Figure 14. Bioresorbable Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2017-2022)
Figure 16. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region in 2021
Figure 17. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Region (2017-2022)
Figure 18. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Region in 2021
Figure 19. United States Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Turkey Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Saudi Arabia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. UAE Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Sales Market Share of Bioresorbable Drug-Eluting Stents by Materials (2017-2022)
Figure 42. Manufacturing Cost Structure of Bioresorbable Drug-Eluting Stents
Figure 43. Manufacturing Process Analysis of Bioresorbable Drug-Eluting Stents
Figure 44. Bioresorbable Drug-Eluting Stents Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
